| This presentation at the APSARD Symposium in Philadelphia 2009 discusses stimulant medication use in adolescents with ADHD. Eli Lilly and Shire sponsored the filming, broadcast and archiving of the content of this symposium. MediCom offered continuing medical education with this content.
|
| Wolraich ML. Methylphenidate may improve symptoms but does not increase response compared with placebo in preschool children with ADHD. Evid Based Ment Health. 2007 May;10(2):60.
Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML; American Academy of Pediatrics Committee on Quality Improvement; American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence. Pediatrics. 2005 Jun;115(6):e749-57.
Wolraich ML, Hannah JN, Baumgaertel A, Feurer ID. Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a county-wide sample. J Dev Behav Pediatr. 1998 Jun;19(3):162-8.
Wolraich ML, Lindgren S, Stromquist A, Milich R, Davis C, Watson D Stimulant medication use by primary care physicians in the treatment of attention deficit hyperactivity disorder. Pediatrics. 1990 Jul;86(1):95-101.
Stevenson RD, Wolraich ML. Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder. Pediatr Clin North Am. 1989 Oct;36(5):1183-97. |
Brief Description